Literature DB >> 32217618

Covid-19: risk factors for severe disease and death.

Rachel E Jordan1, Peymane Adab2, K K Cheng2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32217618     DOI： 10.1136/bmj.m1198

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  479 in total

1.  Reopening Schools After a Novel Coronavirus Surge.

Authors:  Dan Li; Elizabeth Z Lin; Marie A Brault; Julie Paquette; Sten H Vermund; Krystal J Godri Pollitt
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Unmasking the mask: the role of personal protective equipment for ophthalmologists caring for asymptomatic patients during the COVID-19 pandemic.

Authors:  Adrian T Fung
Journal:  Int J Ophthalmol       Date:  2020-12-18       Impact factor: 1.779

Review 3.  Cutaneous Manifestations in Patients With COVID-19: Clinical Characteristics and Possible Pathophysiologic Mechanisms.

Authors:  F González González; C Cortés Correa; E Peñaranda Contreras
Journal:  Actas Dermosifiliogr       Date:  2021-01-28

4.  Burden and prevalence of prognostic factors for severe COVID-19 in Sweden.

Authors:  Katalin Gémes; Mats Talbäck; Karin Modig; Anders Ahlbom; Anita Berglund; Maria Feychting; Anthony A Matthews
Journal:  Eur J Epidemiol       Date:  2020-05-18       Impact factor: 8.082

5.  The Neat Dance of COVID-19: NEAT1, DANCR, and Co-Modulated Cholinergic RNAs Link to Inflammation.

Authors:  Chanan Meydan; Nimrod Madrer; Hermona Soreq
Journal:  Front Immunol       Date:  2020-10-09       Impact factor: 7.561

6.  Neuropathology of COVID-19 (neuro-COVID): clinicopathological update.

Authors:  Jerry J Lou; Mehrnaz Movassaghi; Dominique Gordy; Madeline G Olson; Ting Zhang; Maya S Khurana; Zesheng Chen; Mari Perez-Rosendahl; Samasuk Thammachantha; Elyse J Singer; Shino D Magaki; Harry V Vinters; William H Yong
Journal:  Free Neuropathol       Date:  2021-01-18

7.  The Pathology of Severe COVID-19-Related Lung Damage.

Authors:  Felix K F Kommoss; Constantin Schwab; Luca Tavernar; Johannes Schreck; Willi L Wagner; Uta Merle; Danny Jonigk; Peter Schirmacher; Thomas Longerich
Journal:  Dtsch Arztebl Int       Date:  2020-07-20       Impact factor: 5.594

8.  Is Gradual and Controlled Approach to Herd Protection a Valid Strategy to Curb the COVID-19 Pandemic?

Authors:  Ramanan Laxminarayan; T Jacob John
Journal:  Indian Pediatr       Date:  2020-05-06       Impact factor: 1.411

Review 9.  [Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic].

Authors:  H Javelot; P-M Llorca; D Drapier; E Fakra; C Hingray; G Meyer; S Dizet; A Egron; C Straczek; M Roser; M Masson; R Gaillard; P Fossati; E Haffen
Journal:  Encephale       Date:  2020-05-04       Impact factor: 1.291

10.  The CREST-2 experience with the evolving challenges of COVID-19: A clinical trial in a pandemic.

Authors:  James F Meschia; Kevin M Barrett; Robert D Brown; Tanya N Turan; Virginia J Howard; Jenifer H Voeks; Brajesh K Lal; George Howard; Thomas G Brott
Journal:  Neurology       Date:  2020-05-01       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.